Celldex Therapeutics Earnings Calls

Q1 2025 Missed
-$0.81 (-8.00%)
Release date May 08, 2025
EPS estimate -$0.750
EPS actual -$0.81
EPS Surprise -8.00%
Revenue estimate 1.121M
Revenue actual 695K
Revenue Surprise -37.99%
Q4 2024 Beat
-$0.710 (2.74%)
Release date Feb 27, 2025
EPS estimate -$0.730
EPS actual -$0.710
EPS Surprise 2.74%
Revenue estimate 1.252M
Revenue actual 1.175M
Revenue Surprise -6.15%
Q3 2024 Beat
-$0.640 (7.25%)
Release date Nov 06, 2024
EPS estimate -$0.690
EPS actual -$0.640
EPS Surprise 7.25%
Revenue estimate 1.09M
Revenue actual 3.191M
Revenue Surprise 192.75%
Q2 2024 Beat
-$0.540 (8.47%)
Release date Aug 08, 2024
EPS estimate -$0.590
EPS actual -$0.540
EPS Surprise 8.47%
Revenue estimate 820K
Revenue actual 2.498M
Revenue Surprise 204.63%

Last 4 Quarters for Celldex Therapeutics

Below you can see how CLDX performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

Q2 2024 Beat
Release date Aug 08, 2024
Fiscal end date Jun 30, 2024
Price on release $32.71
EPS estimate -$0.590
EPS actual -$0.540
EPS surprise 8.47%
Date Price
Aug 02, 2024 $34.78
Aug 05, 2024 $32.72
Aug 06, 2024 $33.51
Aug 07, 2024 $32.06
Aug 08, 2024 $32.71
Aug 09, 2024 $32.92
Aug 12, 2024 $33.46
Aug 13, 2024 $33.28
Aug 14, 2024 $32.33
4 days before -5.95%
4 days after -1.16%
On release day 0.642%
Change in period -7.04%
Q3 2024 Beat
Release date Nov 06, 2024
Fiscal end date Sep 30, 2024
Price on release $27.63
EPS estimate -$0.690
EPS actual -$0.640
EPS surprise 7.25%
Date Price
Oct 31, 2024 $26.06
Nov 01, 2024 $25.68
Nov 04, 2024 $25.39
Nov 05, 2024 $25.43
Nov 06, 2024 $27.63
Nov 07, 2024 $26.47
Nov 08, 2024 $26.22
Nov 11, 2024 $26.21
Nov 12, 2024 $27.01
4 days before 6.02%
4 days after -2.24%
On release day -4.20%
Change in period 3.65%
Q4 2024 Beat
Release date Feb 27, 2025
Fiscal end date Dec 31, 2024
Price on release $20.31
EPS estimate -$0.730
EPS actual -$0.710
EPS surprise 2.74%
Date Price
Feb 21, 2025 $22.46
Feb 24, 2025 $21.33
Feb 25, 2025 $20.80
Feb 26, 2025 $20.63
Feb 27, 2025 $20.31
Feb 28, 2025 $20.57
Mar 03, 2025 $19.35
Mar 04, 2025 $20.00
Mar 05, 2025 $21.10
4 days before -9.57%
4 days after 3.89%
On release day 1.28%
Change in period -6.06%
Q1 2025 Missed
Release date May 08, 2025
Fiscal end date Mar 30, 2025
Price on release $19.52
EPS estimate -$0.750
EPS actual -$0.81
EPS surprise -8.00%
Date Price
May 02, 2025 $20.66
May 05, 2025 $20.29
May 06, 2025 $18.40
May 07, 2025 $18.91
May 08, 2025 $19.52
May 09, 2025 $18.33
4 days before -5.52%
4 days after -6.10%
On release day -6.10%
Change in period -11.28%

Celldex Therapeutics Earnings History

Earnings Calendar

FAQ

When is the earnings report for CLDX?
Celldex Therapeutics (CLDX) has scheduled its earnings report for Aug 14, 2025 after the markets close.

What is the CLDX price-to-earnings (P/E) ratio?
CLDX P/E ratio as of May 09, 2025 (TTM) is -7.95.

What is the CLDX EPS forecast?
The forecasted EPS (Earnings Per Share) for Celldex Therapeutics (CLDX) for the first fiscal quarter 2025 is -$0.81.

What are Celldex Therapeutics's retained earnings?
On its balance sheet, Celldex Therapeutics reported retained earnings of $695.00 thousand for the latest quarter ending Mar 30, 2025.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT CELLDEX THERAPEUTICS
Celldex Therapeutics
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity...
GOLDEN STAR
Ticker Change Signal Date
BAX
$30.72
0.586% May 07
HBM
$7.41
4.05% May 05
P
PENG
$17.23
2.21% May 05
A
AORT
$23.77
21.62% May 05
PODD
$257.01
20.88% May 02

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE